Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Iceland
Olmesartan 10mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Olmesartan 10 mg film-coated tablets are white, round, biconvex and 6.5mm in diameter, with OL 10 debossed on one side. |
Olmesartan medoxomil.
Each 10 mg tablet contains 10 mg of olmesartan medoxomil.
Excipients with known effect: Each 10 mg tablet contains 75.53mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Olmesartan medoxomil |
Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations. |
| List of Excipients |
|---|
|
Tablet core: Cellulose, microcrystalline Film-coating: Opadry II White 33G28435 containing: Titanium dioxide (E171) |
Aluminium/aluminium blister pack.
Packs of 7, 10, 14, 28, 30, 56, 60, 84, 90, 98 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Iceland
PL 30306/0701
18/08/2016 / 16/05/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
